News & Updates
Filter by Specialty:
Show Multimedia Only

JAK inhibitor a new hope for new-onset T1D?
02 Oct 2025
byAudrey Abella
The 2-year outcomes from the phase II BANDIT* trial confirm the potential of the Janus kinase (JAK) inhibitor baricitinib for the treatment of new-onset type 1 diabetes (T1D).
JAK inhibitor a new hope for new-onset T1D?
02 Oct 2025
Hypertensive disorders of pregnancy may impair childhood neurodevelopment
22 Sep 2025
byStephen Padilla
Hypertensive disorders of pregnancy (HDPs) appear to increase the odds of adverse neurodevelopmental and cognitive outcomes, such as autism and attention-deficit/hyperactivity disorder (ADHD), in the offspring, suggest the results of a meta-analysis.